
Research Square (Research Square), Journal Year: 2025, Volume and Issue: unknown
Published: March 17, 2025
Language: Английский
Research Square (Research Square), Journal Year: 2025, Volume and Issue: unknown
Published: March 17, 2025
Language: Английский
Experimental Gerontology, Journal Year: 2025, Volume and Issue: 200, P. 112676 - 112676
Published: Jan. 10, 2025
Age-related hearing loss (ARHL) is a common sensory disorder with significant public health implications. However, few effective treatment options are available. Mendelian randomization (MR) has been used to repurpose existing drugs and identify new therapeutic targets. Therefore, we performed systematic genome-wide MR of drug-eligible individuals explore potential targets for ARHL. We obtained data on the expression quantitative trait locis (eQTLs) druggable genes, which were then subjected two-sample analyses co-localisation from ARHL association study genes highly associated Additionally, conducted phenome-wide research, enrichment analysis, protein network construction, drug prediction, molecular docking help develop more targeted treatments. Overall, analysis eQTL showed that 14 significantly GO revealed their primary involvement in biological processes such as endoplasmic reticulum unfolded response, ER-nucleus signaling pathway, fibroblast apoptotic process. important cellular components include Bcl-2 family proteins lumen. After filtering using methods docking, six potentially (BAK1, AMFR, LAMP3, STK17B, ACP5, CD9) (beclomethasone, propyl pyrazole triol, momelotinib, monoisoamyl-2,3-dimercaptosuccinate, pterostilbene, naftidrofuryl) may affect outcomes finally identified. Our findings identified These offer promising leads treatments determine priority development, reducing costs.
Language: Английский
Citations
0Geriatric Nursing, Journal Year: 2025, Volume and Issue: 63, P. 8 - 14
Published: March 13, 2025
Language: Английский
Citations
0Pharmaceuticals, Journal Year: 2025, Volume and Issue: 18(2), P. 246 - 246
Published: Feb. 12, 2025
Aging is a process characterized by tissue degeneration, increased susceptibility to chronic degenerative diseases, infections, and the appearance of neoplasms, which leads disability reduction in length quality life. This phenomenon result convergence multiple processes, including mitochondrial dysfunction, fibrosis, inflammation, dysregulation cell death immunosenescence. These processes have as their point an increase production ROS. Avocado oil (Persea americana Mill.) contains diverse array bioactive compounds, oleic acid, phytosterols, chlorophylls, xanthones, xanthines, carotenoids. compounds capacity modulate excessive ROS, thereby reducing progression age-related diseases extending lifespan experimental models aging. In addition, several studies demonstrated efficacy avocado mitigating hypertension; insulin resistance; diabetes; non-alcoholic liver disease; such hearing loss, cognitive decline, neurodegeneration, impaired wound healing. light these findings, it hypothesized that promising agent capable promoting healthspan later stages life owing its direct antioxidant actions activation pathways enhance endogenous levels.
Language: Английский
Citations
0Research Square (Research Square), Journal Year: 2025, Volume and Issue: unknown
Published: March 17, 2025
Language: Английский
Citations
0